Log in to save to my catalogue

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-...

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f57f8334dd84f27b5e4ba53b577997f

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study

About this item

Full title

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2017-06, Vol.21 (1), p.134-134, Article 134

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The purpose of this study was to investigate whether polymyxin B hemoperfusion (PMX-HP) improves the survival of patients with septic shock.
This was a retrospective, multicenter study conducted on patients treated during a 3-year period. We performed propensity-score analyses of the Japan Septic Disseminated Intravascular Coagulation (JSEPTIC D...

Alternative Titles

Full title

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2f57f8334dd84f27b5e4ba53b577997f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f57f8334dd84f27b5e4ba53b577997f

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1466-609X,1366-609X

DOI

10.1186/s13054-017-1712-3

How to access this item